Lecanemab for Alzheimer's disease
- PMID: 36535691
- DOI: 10.1136/bmj.o3010
Lecanemab for Alzheimer's disease
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare no other interests. Provenance and peer review: Commissioned; not externally peer reviewed.
Comment in
-
Need for truthfulness in dementia research.BMJ. 2023 Feb 1;380:255. doi: 10.1136/bmj.p255. BMJ. 2023. PMID: 36724908 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical